Impact of the 340B Drug Pricing Program on Cancer Care Site and Spending in Medicare.
Jeah JungWendy Yi XuYamini KalidindiPublished in: Health services research (2018)
The 340B program shifted the site of cancer drug administration to HOPDs and increased spending on other cancer care. As the program expands, continuing assessment of its impact on service utilization and spending would be needed.